PAVMED INC (PAVM) Fundamental Analysis & Valuation

NASDAQ:PAVM • US70387R5028

10.42 USD
+0.01 (+0.1%)
Last: Mar 6, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This PAVM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Overall PAVM gets a fundamental rating of 2 out of 10. We evaluated PAVM against 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PAVM have multiple concerns. PAVM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. PAVM Profitability Analysis

1.1 Basic Checks

  • PAVM had negative earnings in the past year.
  • In the past year PAVM has reported a negative cash flow from operations.
  • In the past 5 years PAVM reported 4 times negative net income.
  • PAVM had a negative operating cash flow in each of the past 5 years.
PAVM Yearly Net Income VS EBIT VS OCF VS FCFPAVM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M -80M

1.2 Ratios

  • PAVM has a better Return On Assets (-1.56%) than 71.20% of its industry peers.
  • With a decent Return On Equity value of -1.66%, PAVM is doing good in the industry, outperforming 72.28% of the companies in the same industry.
Industry RankSector Rank
ROA -1.56%
ROE -1.66%
ROIC N/A
ROA(3y)-87.06%
ROA(5y)-98.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PAVM Yearly ROA, ROE, ROICPAVM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K

1.3 Margins

  • PAVM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PAVM Yearly Profit, Operating, Gross MarginsPAVM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. PAVM Health Analysis

2.1 Basic Checks

  • PAVM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for PAVM has been increased compared to 1 year ago.
  • Compared to 5 years ago, PAVM has more shares outstanding
  • PAVM has a better debt/assets ratio than last year.
PAVM Yearly Shares OutstandingPAVM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
PAVM Yearly Total Debt VS Total AssetsPAVM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • PAVM has an Altman-Z score of -8.67. This is a bad value and indicates that PAVM is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -8.67, PAVM is not doing good in the industry: 76.63% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.19 indicates that PAVM is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.19, PAVM is in line with its industry, outperforming 58.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z -8.67
ROIC/WACCN/A
WACC7.36%
PAVM Yearly LT Debt VS Equity VS FCFPAVM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

  • A Current Ratio of 0.40 indicates that PAVM may have some problems paying its short term obligations.
  • PAVM has a Current ratio of 0.40. This is amonst the worse of the industry: PAVM underperforms 93.48% of its industry peers.
  • PAVM has a Quick Ratio of 0.40. This is a bad value and indicates that PAVM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.40, PAVM is doing worse than 93.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
PAVM Yearly Current Assets VS Current LiabilitesPAVM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. PAVM Growth Analysis

3.1 Past

  • PAVM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -388.28%.
  • The Revenue for PAVM has decreased by -99.28% in the past year. This is quite bad
  • The Revenue has been growing by 81.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-388.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-704.17%
Revenue 1Y (TTM)-99.28%
Revenue growth 3Y81.61%
Revenue growth 5YN/A
Sales Q2Q%-99.5%

3.2 Future

  • The Earnings Per Share is expected to decrease by -243.06% on average over the next years. This is quite bad
  • The Revenue is expected to grow by 142.05% on average over the next years. This is a very strong growth
EPS Next Y-76.54%
EPS Next 2Y-243.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-97.58%
Revenue Next 2Y-63.49%
Revenue Next 3Y268.29%
Revenue Next 5Y142.05%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PAVM Yearly Revenue VS EstimatesPAVM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
PAVM Yearly EPS VS EstimatesPAVM Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -100 -200 -300 -400

More info and screens

Find the best growth stocksShow best growing peers

0

4. PAVM Valuation Analysis

4.1 Price/Earnings Ratio

  • PAVM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year PAVM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PAVM Price Earnings VS Forward Price EarningsPAVM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PAVM Per share dataPAVM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20

4.3 Compensation for Growth

  • PAVM's earnings are expected to decrease with -243.06% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-243.06%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PAVM Dividend Analysis

5.1 Amount

  • PAVM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PAVM Fundamentals: All Metrics, Ratios and Statistics

PAVMED INC

NASDAQ:PAVM (3/6/2026, 8:00:02 PM)

10.42

+0.01 (+0.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)03-23
Inst Owners7.04%
Inst Owner Change29.12%
Ins Owners5.58%
Ins Owner Change15.5%
Market Cap14.90M
Revenue(TTM)29.00K
Net Income(TTM)-595.00K
Analysts82.5
Price Target321.3 (2983.49%)
Short Float %12.1%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-262.66%
Min EPS beat(2)-458.07%
Max EPS beat(2)-67.24%
EPS beat(4)2
Avg EPS beat(4)-4.76%
Min EPS beat(4)-458.07%
Max EPS beat(4)356.41%
EPS beat(8)4
Avg EPS beat(8)-9.4%
EPS beat(12)7
Avg EPS beat(12)-3.45%
EPS beat(16)7
Avg EPS beat(16)-6.47%
Revenue beat(2)0
Avg Revenue beat(2)-60.78%
Min Revenue beat(2)-80.39%
Max Revenue beat(2)-41.18%
Revenue beat(4)0
Avg Revenue beat(4)-60.36%
Min Revenue beat(4)-98.31%
Max Revenue beat(4)-21.57%
Revenue beat(8)0
Avg Revenue beat(8)-35.03%
Revenue beat(12)2
Avg Revenue beat(12)-31.9%
Revenue beat(16)2
Avg Revenue beat(16)-39.94%
PT rev (1m)0%
PT rev (3m)2525%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2900%
EPS NY rev (1m)0%
EPS NY rev (3m)-2100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-39.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 359.31
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.29
EV/EBITDA N/A
EPS(TTM)-20.41
EYN/A
EPS(NY)-24.48
Fwd EYN/A
FCF(TTM)-3.58
FCFYN/A
OCF(TTM)-3.56
OCFYN/A
SpS0.03
BVpS35.78
TBVpS35.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.56%
ROE -1.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-87.06%
ROA(5y)-98.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.46%
Cap/Sales 72.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.4
Quick Ratio 0.4
Altman-Z -8.67
F-Score2
WACC7.36%
ROIC/WACCN/A
Cap/Depr(3y)25.15%
Cap/Depr(5y)202.92%
Cap/Sales(3y)138.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-388.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-704.17%
EPS Next Y-76.54%
EPS Next 2Y-243.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-99.28%
Revenue growth 3Y81.61%
Revenue growth 5YN/A
Sales Q2Q%-99.5%
Revenue Next Year-97.58%
Revenue Next 2Y-63.49%
Revenue Next 3Y268.29%
Revenue Next 5Y142.05%
EBIT growth 1Y63.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year93.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y93.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.75%
OCF growth 3YN/A
OCF growth 5YN/A

PAVMED INC / PAVM FAQ

What is the fundamental rating for PAVM stock?

ChartMill assigns a fundamental rating of 2 / 10 to PAVM.


What is the valuation status of PAVMED INC (PAVM) stock?

ChartMill assigns a valuation rating of 0 / 10 to PAVMED INC (PAVM). This can be considered as Overvalued.


Can you provide the profitability details for PAVMED INC?

PAVMED INC (PAVM) has a profitability rating of 1 / 10.


How financially healthy is PAVMED INC?

The financial health rating of PAVMED INC (PAVM) is 1 / 10.